An innovative approach to screening and chemoprophylaxis among contacts of leprosy patients in low endemic settings: experiences from Cambodia

Arielle Cavaliero; Helena Greter; Thomas Fürst; Sambath Lay; Sarady Sao Ay; Jan Robijn; Peter Steinmann

doi:10.1371/journal.pntd.0007039

An innovative approach to screening and chemoprophylaxis among contacts of leprosy patients in low endemic settings: experiences from Cambodia

PLoS Negl Trop Dis. 2019 Mar 28;13(3):e0007039. doi: 10.1371/journal.pntd.0007039. eCollection 2019 Mar.

Authors

Arielle Cavaliero¹, Helena Greter^{2

3}, Thomas Fürst^{2

3}, Sambath Lay⁴, Sarady Sao Ay^{2

3}, Jan Robijn⁵, Peter Steinmann^{2

3}

Affiliations

¹ Novartis Foundation, Basel, Switzerland.
² Swiss Tropical and Public Health Institute, Basel, Switzerland.
³ University of Basel, Basel, Switzerland.
⁴ National Leprosy Elimination Program, Phnom Penh, Cambodia.
⁵ Netherlands Leprosy Relief, Hanoi, Vietnam.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Cambodia / epidemiology
Chemoprevention / methods*
Communicable Disease Control / organization & administration*
Disease Transmission, Infectious / prevention & control*
Endemic Diseases
Humans
Leprosy / diagnosis*
Leprosy / epidemiology
Leprosy / prevention & control*
Leprosy / transmission
Mass Screening / methods*

Grants and funding

The LPEP program is funded by the Novartis Foundation (https://www.novartisfoundation.org). Novartis Foundation provided technical input in the design phase of the RACF approach and LPEP program, and ensures overall program coordination. The funder had no role in the data collection, analysis and interpretation of findings or decision to publish and preparation of this manuscript.